MicroRNA-451 in chronic myeloid leukemia: miR-451–BCR-ABL regulatory loop?

Agirre, 2008, Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth, Mol Cancer Res, 6, 1830, 10.1158/1541-7786.MCR-08-0167 Calin, 2005, MicroRNAs and leukemias: how strong is the connection?, Leuk Res, 30, 653, 10.1016/j.leukres.2005.10.017 Pelosi, 2009, MicroRNAs in normal and malinant myelopoiesis, Leuk Res, 33, 1584, 10.1016/j.leukres.2009.04.039 Polakova, 2008, Differential expression of miRNAs during the course of chronic myeloid leukemia (abstract), Blood, 112, 395, 10.1182/blood.V112.11.1082.1082 ten Hoeve, 1994, Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia, Blood, 84, 1731, 10.1182/blood.V84.6.1731.1731 Cilloni, 2004, Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation, Cancer, 101, 979, 10.1002/cncr.20457 Zackova, 2010, In vitro sensitivity to tyrosine kinase inhibitors is one of possible predictive parameters for therapy switch in patients with chronic myeloid leukemia (abstract), Blood, 116, 1133, 10.1182/blood.V116.21.2747.2747 Iraci, 2009, Suppression of BCR-ABL expression in CML by a panel of miRNAs (abstract), Blood, 114, 351, 10.1182/blood.V114.22.854.854